Form 8-K - Current report:
SEC Accession No. 0001193125-19-292868
Filing Date
2019-11-15
Accepted
2019-11-15 07:31:02
Documents
3
Period of Report
2019-11-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d832662d8k.htm 8-K 18084
2 EX-99.1 d832662dex991.htm EX-99.1 12089
3 GRAPHIC g832662img01.jpg GRAPHIC 13417
  Complete submission text file 0001193125-19-292868.txt   49882
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 191222478
SIC: 2834 Pharmaceutical Preparations